|
In 2002, Dr. Turner received his PhD in nutritional sciences and toxicology from the University of California at Berkeley. His graduate research focused on the development and application of stable isotope methodology to the study of adipose tissue dynamics in the ob/ob mouse, a well-known model of obesity. Before entering graduate school, he trained for several years as a research technician in the laboratory of Dr. Marc Hellerstein, where he performed GC/MS analysis and physiology studies of glucose and lipid metabolism. After his graduate studies, he joined KineMed, Inc., where he was instrumental in establishing it as the leader in the field of stable isotope research and applications in drug discovery and development. Dr. Turner has authored or co-authored more than 15 papers and holds several patents in the area of metabolic fluxes and stable isotopes methodology. Dr. Turner has been awarded two NIH grants to fund his research into novel in vivo applications of stable isotopes in disease and serves on the editorial board of Biomarker Insights. Within the scope of his duties as Vice President of Operations at KineMed, he most currently leads the research and development efforts in reverse cholesterol transport. | 